Home › Endometrial Cancer › Idaho › Boise
Endometrial Cancer clinical trials in Boise, ID
3 studies for Endometrial Cancer are looking for participants at sites in and around Boise (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Saint Luke's Cancer Institute - Boise, Boise
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Boise
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Other studies in Boise
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Colon Cancer7 studies
- Breast Cancer6 studies
- Melanoma6 studies
- Colorectal Cancer6 studies
- Respiratory Distress Syndrome6 studies
- Burkitt Lymphoma5 studies
- Traumatic Brain Injury4 studies
- Post-Concussion Syndrome4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.